X4 Pharmaceuticals issues options for 80,000 shares under 2019 inducement plan for new hires

• X4 Pharmaceuticals issued inducement stock options for 80,000 shares to new employees under its 2019 Inducement Equity Incentive Plan.
• Options carry a 10-year term with an exercise price of $2.90 per share, set at the Sept. 30, 2026 close.
• Vesting runs four years: 25% after 12 months, then monthly over the next 36 months, contingent on continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. X4 Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610011630PRIMZONEFULLFEED9838184) on October 01, 2026, and is solely responsible for the information contained therein.